Results 31 to 40 of about 8,347 (150)
Paraneoplastic Neurologic Syndromes.
Paraneoplastic neurologic syndromes are degenerative diseases of the central or peripheral nervous system that develop in association with a systemic neoplasm without a direct invasion by tumor. The pathogenesis of this disorder has been hypothesized in the past, and now there is increasing evidence that autoimmune processes triggered by the underlying
openaire +5 more sources
Anti-Ma and anti-Ma2-associated paraneoplastic neurological syndromes
Objective: Analyse the clinical profile, associated tumour types, and response to treatment of paraneoplastic neurological syndromes associated with antibodies against Ma proteins.
G. Ortega Suero +4 more
doaj +1 more source
Summary: Background: Immune checkpoint inhibitor-related encephalitis (ICI-encephalitis) is not well characterised and diagnostic and prognostic biomarkers are lacking.
Antonio Farina +26 more
doaj +1 more source
Paraneoplastic neurological syndrome: focus on the involvement of the peripheral nervous system [PDF]
The information about epidemiology, pathogenesis and clinical heterogeneity of paraneoplastic neurological syndrome is summarized and based on Russian and foreign literature. The main attention is devoted to the affection of peripheral nervous systems in
Sitkali I.V., Kolokolov O.V.
doaj
Paraneoplastic motor neuron disease in a patient with sigmoid colon adenocarcinoma - a case report [PDF]
Background. Paraneoplastic neurological syndromes (PNS) are a rare and diverse group of disorders caused by immune-mediated effects of malignancies. Affecting less than 1% of all cancer patients, these syndromes often present diagnostic and therapeutic ...
Keesari Sai Sandeep REDDY +4 more
doaj +1 more source
Diagnosis of paraneoplastic neurological syndromes
Aproximadamente 3 por ciento de todos pacientes con cáncer pulmonar de pequeñas células (SCLC) y el 0,2 por ciento de todos pacientes con cáncer de los ovarios desarrollarán un síndrome neurológico paneoplásico (SPN).
Camilo E Fadul MD
doaj +2 more sources
Immune checkpoint inhibitors (ICI), i.e., anti-PD1/PDL1 and anti-CTLA-4, have reshaped the prognosis of many cancers. Increased use of ICI has led to the onset of new adverse events.
Morgan Zenatri +10 more
doaj +1 more source
Paraneoplastic neurological syndromes (PNS) are rare and relatively unusual in day to day clinical practice. Occasionally, PNS may be the heralding manifestation of the malignancy.
Rajesh Verma +3 more
doaj +1 more source
The Clinical Concept of LTDpathy: Is Dysregulated LTD Responsible for Prodromal Cerebellar Symptoms?
Long-term depression at parallel fibers-Purkinje cells (PF-PC LTD) is essential for cerebellar motor learning and motor control. Recent progress in ataxiology has identified dysregulation of PF-PC LTD in the pathophysiology of certain types of immune ...
Hiroshi Mitoma +3 more
doaj +1 more source
Opsoclonus-myoclonus syndrome associated with pancreatic neuroendocrine tumor: a case report
Background Opsoclonus-myoclonus syndrome (OMS) is a rare, immune-mediated neurological disorder. In adults, the pathogenesis can be idiopathic, post-infectious or paraneoplastic, the latter etiology belonging to the ever-expanding group of defined ...
Raphael Reinecke +4 more
doaj +1 more source

